Latest Headlines

31. Southwest Labs Now Offers A Fast, 20 Minute Rapid COVID-19 Antigen Test 10/12/2020

    Southwest Labs has recently announced that they are now offering a NEW Rapid COVID-19 Antigen Test

32. Exact Sciences Introduces The Oncotype MAP™ Pan-Cancer Tissue Test To Help Guide Treatment For Patients With Advanced Cancer 10/12/2020

    Exact Sciences Corp. (NASDAQ: EXAS) today announced the introduction of the Oncotype MAP™ Pan-Cancer Tissue test for patients with advanced, metastatic, refractory, or recurrent cancer

33. Alconox Announces Oct 22 Life Sciences Webinar For Cleaning Validation , COVID-19 Sanitary Surface Considerations 10/7/2020

    Introduction and general cleaning concepts including detergent selections and chemistry in Life Sciences

34. Lucence Launches DeepMARK For Profiling Of SARS-CoV-2 Subgenomic RNA 10/6/2020

    Molecular diagnostics company Lucence today announced the availability of the world’s first assay kit to directly profile SARS-CoV-2 subgenomic RNA (sgRNA), a marker of active viral replication, from clinical samples

35. Empower Clinics Acquires Medical Laboratory Capable Of Processing 4,000 Covid-19 RT-PCR Tests Per Day 10/6/2020

    EMPOWER CLINICS INC. (“Empower” or the “Company”) is pleased to announce that, pursuant to the terms of a membership interest purchase agreement dated October 5, 2020, has completed the acquisition of Kai Medical Laboratory, LLC (“KAI”) from KTM5 Holdings, LLC, NULV11, LLC and Consistent Investment Group, LLC (together, the “Vendors”), through its wholly-owned subsidiary, Empower Healthcare Assets Inc. (“Empower Health”), for consideration having an aggregate value of US$1,971,857 (CAD$2,613,478), effective as of October 5, 2020 (the “Transaction”)

36. Agendia, HiSS Diagnostics And PathoNext Offer Local MammaPrint And BluePrint Testing For Breast Cancer Patients In Germany 10/6/2020

    Agendia Inc., a world leader in precision oncology for breast cancer, announced today the availability of local testing for its CE-marked MammaPrint® BluePrint® Breast Cancer Recurrence and Molecular Subtyping tests, provided by PathoNext lab in Leipzig, Germany

37. Precipio & ADS Biotec Launch Seven Beta Sites For IV-Cell™ 10/6/2020

    Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), along with its partner ADS Biotec announce the launch of the beta phase testing for its new IV-cell cytogenetics culturing media

38. QIAGEN To Complement COVID-19 Testing Portfolio With Novel Kit That Simplifies And Accelerates PCR Analysis For Research Applications 10/5/2020

    QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to launch a novel straightforward approach to viral RNA epidemiology that will significantly simplify and accelerate PCR analysis and remove key testing bottlenecks for SARS-CoV-2 and other RNA viruses

39. Gold Standard Diagnostics Receives FDA 510K For Lyme IgG And IgM EIA Kits 10/5/2020

    The Gold Standard Diagnostics Group (GSD) today announced the immediate availability of their two new Lyme IgG and Lyme IgM EIA kits for detection of antibodies against Lyme disease causing bacteria

40. New Service For Ultra-Low Temperature TSX Freezers Enables Active Sample And Product Protection 10/5/2020

    Life science research and clinical laboratories working with temperature-sensitive samples can now benefit from a new service designed to enable Thermo Fisher Scientific’s dedicated team of technical experts to keep "digital eyes" on wifi-connected Thermo Scientific TSX Series Ultra-Low Temperature (ULT) Freezers